FDA Recommends Remote Monitoring

Sep 1, 2011Clinical Trial

In this technological age, monitoring clinical trials done remotely,  and no longer requires traveling to a destination to check up on the investigators. The FDA, is encouraging sponsors to undertake more of what the agency calls risk-based monitoring in order to match international standards articulated by the International Conference on Harmonisation. Read the full article about the FDA encouraging remote monitoring.

JeanBrownResearch.com is a Salt Lake City based trial research organization, specializing in pain management and diabetic studies, among other types of  clinical trials. Follow us on Twitter and Facebook

Translate »